Central causes of hypogonadism-functional and organic

Endocrinology and Metabolism Clinics of North America

Volumn 32, Issue 3, 2003, Pages 593-612

  Warren, Michelle P ^a   Vu, Caroline ^a  

^a Columbia Coll of Phys and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE;

ALCOHOL CONSUMPTION; AMENORRHEA; ANOREXIA NERVOSA; CIGARETTE SMOKING; ENVIRONMENTAL FACTOR; EXERCISE; FEMALE; GENE MUTATION; GONADOTROPIN RELEASE; HEAD INJURY; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADISM; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; KALLMANN SYNDROME; ORAL CONTRACEPTION; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PULSE GENERATOR; REVIEW;

EID: 0141621252     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00042-2     Document Type: Review

References (119)

1. Plymate SR. Male hypogonadism. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1125-47.
2. Speroff L, Glass RH, Kase NG. Amenorrhea. In: Speroff L, Glass RH, Klase NG, editors. Clinical gynecologic endocrinology and infertility. 4th edition. Baltimore, MD: Williams & Wilkins; 1989. p. 165-205.
3. Achermann JC, Weiss J, Lee E-J, Jameson JL. Inherited disorders of the gonadotropin hormones. Mol Cell Endocrinol 2001;179:89-96.
4. Hayes FJ, Seminara SB, Crowley WF Jr. Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am 1998;27(4):739-63.
5. Warren MP, Fried JL. Hypothalamic amenorrhea. The effects of environmental stresses on the reproductive system: a central effect of the central nervous system. Endocrinol Metab Clin North Am 2001;30(3):611-23.
6. Elmquist JK, Maratos-Flier E, Saper CB, Flier JS. Unraveling the central nervous system pathways underlying responses to leptin. Nat Neurosci 1998;1(6):445-50.
7. Yura S, Sagawa N, Mise H, Mori T, Masuzaki H, Ogawa Y, et al. A positive umbilical venous-arterial difference of leptin level and its rapid decline after birth. Am J Obstet Gynecol 1998;178(5):926-30.
8. Casanueva FF, Dieguez C. Neuroendocrine regulation and actions of leptin. Front Neuroendocrinol 1999;20(4):317-63.
9. Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA. Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 1997;138(2):855-8.
10. Tezuka M, Irahara M, Ogura K, Kiyokawa M, Tamura T, Matsuzaki T, et al. Effects of leptin on gonadotropin secretion in juvenile female rat pituitary cells. Eur J Endocrinol 2002;146(2):261-6.
11. Chan JL, Mantzoros CS. Leptin and the hypothalamic-pituitary regulation of the gonadotropin-gonadal axis. Pituitary 2001;4(1-2):87-92.
12. Baldelli R, Dieguez C, Casanueva FF. The role of leptin in reproduction: experimental and clinical aspects. Ann Med 2002;34(1):5-18.
13. Kopp W, Blum WF, von Prittwitz S, Ziegler A, Lubbert H, Emons G, et al. Low leptin levels predict amenorrhea in underweight and eating disordered females. Mol Psychiatry 1997;2(4):335-40.
14. Warren MP, Ramos R, Davis LB. Updates in exercise-associated amenorrhea and leptin. In: Nattiv A, Ireland ML, editors. The female athlete. Philadelphia: Harcourt Health Sciences. In press [chapter 14].
15. Warren MP, Ramos R, Davis LB. Updates in exercise-associated amenorrhea and leptin. In: Nattiv A, Ireland ML, editors. The female athlete. Philadelphia: Harcourt Health Sciences; 2003.
16. Warren MP, Perlroth N. The effects of intense exercise on the female reproductive system. J Endocrinol 2001;170(1):3-11.
17. Frisch RE, McArthur JW. Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science 1974;185(4155):949-51.
18. Schneider JE, Wade GN. Letter to the Editor. Am J Phys 1997;273:E231-2.
19. Sanborn CF, Albretch BH, Wagner WW Jr. Athletic amenorrhea: lack of association with body fat. Med Sci Sports Exerc 1987;19(3):207-12.
20. Loucks AB. Exercise training in the normal female. In: Warren MP, Constantini NW, editors. Sports Endocrinology. Totowa, NJ: Humana Press; 2000. p. 165-80.
21. Laughlin GA, Yen SS. Hypoleptinemia in women athletes: absence of a diurnal rhythm with amenorrhea. J Clin Endocrinol Metab 1997;82(1):318-21.
22. Warren MP, Brooks-Gunn J. Delayed menarche in athletes: the role of low energy intake and eating disorders and their relation to bone density. In: Laron Z, Rogol AD, editors. Hormones and sport. New York: Raven Press; 1989. p. 41-54.
23. Myerson M, Gutin B, Warren MP, May M, Contento I, Lee M, et al. Resting metabolic rate and energy balance in amenorrheic and eumenorrheic runners. Med Sci Sports Exerc 1991;23(1):15-22.
24. Emans SJ. Eating disorders in adolescent girls. Pediatr Int 2000;42(1):1-7.
25. Warren MP. Anorexia nervosa and the reproductive axis. In: Adashi EY, editor. Reproductive endocrinology, surgery, and technology. New York: Raven Press; 1995. p. 1039-60.
26. Boyar RM, Hellman LD, Roffwarg H, Katz J, Zumoff B, O'Connor J, et al. Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med 1977;296(4):190-3.
27. Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, et al. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 1986;314(21):1335-42.
28. Hotta M, Shibasaki T, Masuda A, Imaki T, Demura H, Ling N, et al. The responses of plasma adrenocorticotropin and cortisol to corticotropin-releasing hormone (CRH) and cerebrospinal fluid immunoreactive CRH in anorexia nervosa patients. J Clin Endocrinol Metab 1986;62(2):319-24.
29. Grinspoon S, Gulick T, Askari H, Landt M, Lee K, Anderson E, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 1996;81(11):3861-3.
30. Lear SA, Pauly RP, Birmingham CL. Body fat, caloric intake, and plasma leptin levels in women with anorexia nervosa. Int J Eat Disord 1999;26(3):283-8.
31. Matejek N, Weimann E, Witzel C, Molenkamp G, Schwidergall S, Bohles H. Hypoleptinaemia in patients with anorexia nervosa and in elite gymnasts with anorexia athletica. Int J Sports Med 1999;20(7):451-6.
32. Sirakov M, Slavova A. Chronic stress and the degree of anxiety in girls with menstrual cycle disorders. Akush Ginekol [Sofiia] 1989;28(2):514.
33. Facchinetti F, Fava M, Fioroni L, Genazzani AD, Genazzani AR. Stressful life events and affective disorders inhibit pulsatile LH secretion in hypothalamic amenorrhea. Psychoneuroendocrinology 1993;18(5-6):397-404.
34. Laughlin GA, Dominguez CE, Yen SS. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1998;83(1):25-32.
35. Warren MP, Holderness CC, Lesobre V, Tzen R, Vossoughian F, Brooks-Gunn J. Hypothalamic amenorrhea and hidden nutritional insults. J Soc Gynecol Investig 1994;1(1):84-8.
36. Marcus MD, Loucks TL, Berga SL. Psychological correlates of functional hypothalamic amenorrhea. Fertil Steril 2001;76(2):310-6.
37. Shearman RP. Amenorrhea after treatment with oral contraceptives. Lancet 1966;2(7473):1110-1.
38. Whitelaw MJ, Nola VF, Kalman CF. Irregular menses, amenorrhea, and infertility following synthetic progestational agents. JAMA 1966;195(9):780-2.
39. Moghissi KS, Sajed F. Postpill amenorrhea. In: Hafez ESE, editor. Human ovulation. New York: Elsevier; 1979. p. 243.
40. Hull MG, Bromham DR, Savage PE, Barlow TM, Hughes AO, Jacobs HS. Post-pill amenorrhea: a causal study. Fertil Steril 1981;36(4):472-6.
41. Dickey RP, editor. Galactorrhea/post-pill amenorrhea. In: Managing contraceptive pill patients. New Orleans, LA: CIP; 1991. p. 234-6.
42. Christy NP, Warren MP. Disease syndromes of the hypothalamus and anterior pituitary. In: DeGroot LJ, editor. Endocrinology. New York: Grune and Stratton; 1979. p. 215-52.
43. Marshall JC, Eagleson CA, McCartney CR. Hypothalamic dysfunction. Mol Cell Endocrinol 2001;183:29-32.
44. Smanik EJ, Barkoukis H, Mullen KD, McCullogh AJ. The liver and its effect on endocrine function in health and disease. In: Shiff L, Shiff E, editors. Diseases of the liver. Philadelphia: JB Lippincott; 1993. p. 1373.
45. Van Thiel DH, Gavaler JS. Endocrine consequences of alcohol abuse. Alcohol@Alcohol 1990;25:341-4.
46. De Maria N, Colantoni A, Van Thiel DH. The liver and endocrine function. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1870-85.
47. Sato F, Nakamura K, Taguchi M, Aoki H, Aoki T, Yasuda N. Studies on the site of ethanol action in inducing prolactin release in male rats. Metabolism 1996;45(11):1330-4.
48. Emanuele NV, Lapaglia N, Emanuele MA. Impact of acute and chronic ethanol exposure on prolactin in both male and female rats. Endocrine 2001;16(1):29-37.
49. Frias J, Rodriguez R, Torres JM, Ruiz E, Ortega E. Effects of acute alcohol intoxication on pituitary-gonadal axis hormones, pituitary-adrenal axis hormones, beta-endorphin and prolactin in human adolescents of both sexes. Life Sci 2000;67(9):1081-6.
50. Sarkola T, Makisalo H, Fukunaga T, Eriksson CJ. Acute effect of alcohol on estradiol, estrone, progesterone, prolactin, cortisol, and luteinizing hormone in premenopausal women. Alcohol Clin Exp Res 1999;23(6):976-82.
51. McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985;103(3):350-6.
52. Harlow BL, Signorello LB. Factors associated with early menopause. Maturitas 2000;35(1):3-9.
53. Sartori MP, Sellini M, Baccarini S, Fabiani F. Cigarette smoking and hormonal changes in the course of the menstrual cycle. Clin Ter 1993;143(1):15-8.
54. Sano A, Funabashi T, Kawaguchi M, Shinohara K, Kimura F. Intravenous injections of nicotine decrease the pulsatile secretion of LH by inhibiting the gonadotropin-releasing hormone (GnRH) pulse generator activity in female rats. Psychoneuroendocrinology 1999;24(4):397-407.
55. Hodson CA, Davis MC, Burden HW. Effect of prior nicotine treatment on drug induced changes in serum LH concentrations in rats. Life Sci 1997;60(25):2303-8.
56. Morley JE. The endocrinology of the opiates and opioid peptides. Metabolism 1981;30(2):195-209.
57. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, et al. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000;85(6):2215-22.
58. Finch PM, Roberts LJ, Price L, Hadlow NC, Pullan PT. Hypogonadism in patients treated with intrathecal morphine. Clin J Pain 2000;16(3):251-4.
59. Ferin M, Vande Wiele R. Endogenous opioid peptides and the control of the menstrual cycle. Eur J Obstet Gynecol Reprod Biol 1984;18(5-6):365-73.
60. Petty RG. Prolactin and antipsychotic medications: mechanism of action. Schizophr Res 1999;35(Suppl):S67-73.
61. Kleinberg DL, Davis JM, de Coster R, Van Baelen B, Brecher M. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999;19(1):57-61.
62. Malarkey WB, Strauss RH, Leizman DJ, Liggett M, Demers LM. Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids. Am J Obstet Gynecol 1991;165(5 Pt 1):1385-90.
63. Van Steenbergen W, Naert J, Lambrecht S, Scheys I, Lesaffre E, Pelemans W. Suppression of gonadotropin secretion in the hospitalized postmenopausal female as an effect of acute critical illness. Neuroendocrinology 1994;60(2):165-72.
64. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M. Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 1985;60(3):444-50.
65. Baker HW. Reproductive effects of nontesticular illness. Endocrinol Metab Clin North Am 1998;27(4):831-50.
66. Traggiai C, Stanhope R. Delayed puberty. Best Pract Res Clin Endocrinol Metab 2002;16(1):139-51.
67. Spratt DI, Bigos ST, Beitins I, Cox P, Longcope C, Orav J. Both hyper- and hypogonadotropic hypogonadism occur transiently in acute illness: bio- and immunoactive gonadotropins. J Clin Endocrinol Metab 1992;75(6):1562-70.
68. Warren MP. The effects of altered nutritional states, stress, and systemic illness on reproduction in women. In: Vaitukaitis JL, editor. Clinical reproductive neuroendocrinology. New York: Elsevier; 1982. p. 177-206.
69. Chapman RM, Sutcliffe SB, Malpas JS. Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function. JAMA 1979;242(17):1882-4.
70. Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM. Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen. J Clin Oncol 1995;13(1):134-9.
71. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA. Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 1981;304(23):1377-82.
72. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod 1999;14(7):1903-7.
73. Müller J. Disturbance of pubertal development after cancer treatment. Best Pract Res Clin Endocrinol Metab 2002;16(1):91-103.
74. Ogilvy-Stuart AL, Shalet SM. Effect of radiation on the human reproductive system. Environ Health Perspect 1993;101(Suppl):109-16.
75. Samaan NA, Bakdash MM, Caderao JB, Cangir A, Jesse RH Jr, Ballantyne AJ. Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin. Ann Intern Med 1975;83(6):771-7.
76. Constine LS, Woolf PD, Cann D, Mick G, McCormick K, Raubertas RF, et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993;328(2):87-94.
77. American Cancer Society. Breast cancer facts and figures. New York: American Cancer Society; 2001.
78. Beatson W. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases. Lancet 1896;2:104.
79. Mainwaring PN, Dowsett M. LHRH superagonists and antagonists in the treatment of breast cancer. In: Manni A, editor. Contemporary endocrinology. Endocrinology of breast cancer. Totowa, NJ: Humana Press; 1999. p. 313-28.
80. Dowsett M. Use of risk determinants for different breast cancer prevention strategies. Eur J Cancer 2000;36(10):1283-7.
81. Dowsett M, Jacobs S, Aherne J, Smith IE. Clinical and endocrine effects of leuprorelin acetate in pre- and postmenopausal patients with advanced breast cancer. Clin Ther 1992;14(Suppl):97-103.
82. Nicholson RI, Walker KJ, Turkes A, Dyas J, Plowman PN, Williams M, et al. Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer. J Steroid Biochem 1985;23(5B):843-7.
83. Chen A, Kaganovsky E, Rahimipour S, Ben-Aroya N, Okon E, Koch Y. Two forms of gonadotropin-releasing hormone (GnRH) are expressed in human breast tissue and overexpressed in breast cancer: a putative mechanism for the antiproliferative effect of GnRH by down-regulation of acidic ribosomal phosphoproteins P1 and P2. Cancer Res 2002;62(4):1036-44.
84. Newsome JF, Timmons RL, Van Wyk J, Dugger GS. Pituitary stalk section for metastatic carcinoma of the breast. Ann Surg 1971;174(5):769-73.
85. Hryncak PK. Bardet-Biedl syndrome. Optom Vis Sci 2000;77(5):236-43.
86. Bray GA. Laurence, Moon, Bardet, and Biedl: reflections on a syndrome. Obes Res 1995;3(4):383-6.
87. Walvoord EC, Waguespack SG, Pescovitz OH. Precocious and delayed puberty. In: Becker KL, editor. Principles and practice of endocrinology and metabolism. 3rd edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 893-908.
88. Ammann F. Clinical and genetic studies on the Bardet Biedl syndrome in Switzerland. J Genet Human 1970;18(Suppl):1.
89. Burd L, Vesely B, Martsolf J, Kerbeshian J. Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet 1990;37(1):97-9.
90. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: a population-based study. Dev Med Child Neurol 2002;44(4):248-55.
91. Akefeldt A, Tornhage CJ, Gillberg C. A woman with Prader-Willi syndrome gives birth to a healthy baby girl. Dev Med Child Neurol 1999;41(11):789-90.
92. Schulze A, Mogensen H, Hamborg-Petersen B, Graem N, Ostergaard JR, Brondum-Nielsen K. Fertility in Prader-Willi syndrome: a case report with Angelman syndrome in the offspring. Acta Paediatr 2001;90(4):455-9.
93. Banna M, Hoare RD, Stanley P, Till K. Craniopharyngioma in children. J Pediatr 1973;83(5):781-5.
94. Banna M. Craniopharyngioma: based on 160 cases. Br J Radiol 1976;49(579):206-23.
95. Lin KL, Wang HS, Lui TN. Diagnosis and follow-up of craniopharyngiomas with transcranial Doppler sonography. J Ultrasound Med 2002;21(7):801-6.
96. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM. The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998;89(4):547-51.
97. Biller BM. Hyperprolactinemia. Int J Fertil Womens Med 1999;44(2):74-7.
98. Clayton RN. Sporadic pituitary tumours: from epidemiology to use of databases. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13(3):451-60.
99. Vannemreddy PS, Nanda A, Reddy PK, Gonzalez E. Primary cerebral sarcoid granuloma: the importance of definitive diagnosis in the high-risk patient population. Clin Neurol Neurosurg 2002;104(4):289-92.
100. Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, Zecca S, et al. Central diabetes insipidus in children and young adults. N Engl J Med 2000;343(14):998-1007.
101. Sampathkumar S, Younger C, Cramer H, Chalasani N, Skierczynski PA. Langerhans' cell histiocytosis involving the pituitary, thyroid, lung, and liver. Endocr Pract 2002;8(3):217-21.
102. Egeler RM, Favara BE, van Meurs M, Laman JD, Claassen E. Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment. Blood 1999;94(12):4195-201.
103. Kontogeorgos G, Handy S, Kovacs K, Horvath E, Scheithauer BW. The anterior pituitary in hemochromatosis. Endocr Pathol 1996;7(2):159-64.
104. Yuan XQ, Wade CE. Neuroendocrine abnormalities in patients with traumatic brain injury. Front Neuroendocrinol 1991;12(3):209-30.
105. Seminara SB, Oliveira LM, Beranova M, Hayes FJ, Crowley WF Jr. Genetics of hypogonadotropic hypogonadism. J Endocrinol Invest 2000;23(9):560-5.
106. Seminara SB, Crowley WF Jr. Perspective: the importance of genetic defects in humans in elucidating the complexities of the hypothalamic-pituitary-gonadal axis. Endocrinology 2001;142(6):2173-7.
107. Hardelin JP. Kallmann syndrome: towards molecular pathogenesis. Mol Cell Endocrinol 2001;179(1-2):75-81.
108. Kallmann FJ, Schoenfeld WA, Barrera SE. The genetic aspects of primary eunuchoidism. Am J Ment Defic 1944;48:203-36.
109. Jones JR, Kemmann E. Olfacto-genital dysplasia in the female. Obstet Gynecol Annu 1976;5:443-66.
110. Seminara SB, Hayes FJ, Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev 1998;19(5):521-39.
111. MacColl G, Quinton R, Bouloux PM. GnRH neuronal development: insights into hypogonadotrophic hypogonadism. Trends Endocrinol Metab 2002;13(3):112-8.
112. Sedlmeyer IL, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab 2002;87(4):1613-20.
113. Mecklenburg RS, Loriaux DL, Thompson RH, Andersen AE, Lipsett MB. Hypothalamic dysfunction in patients with anorexia nervosa. Medicine [Baltimore] 1974;53(2):147-59.
114. Vigersky RA, Loriaux DL, Andersen AE, Lipsett MB. Anorexia nervosa: behavioural and hypothalamic aspects. Clin Endocrinol Metab 1976;5(2):517-35.
115. Reeves AG, Plum F. Hyperphagia, rage, and dementia accompanying a ventromedial hypothalamic neoplasm. Arch Neurol 1969;20(6):616-24.
116. Stanhope R, Brook CG, Pringle PJ, Adams J, Jacobs HS. Induction of puberty by pulsatile gonadotropin releasing hormone. Lancet 1987;2(8558):552-5.
117. Delemarre-Van de Waal HA, Odink RJ. Pulsatile GnRH treatment in boys and girls with idiopathic hypogonadotrophic hypogonadism. Hum Reprod 1993;8(Suppl):180-3.
118. Quinton R, Barnett P, Coskeran P, Bouloux PM. Gordon Holmes spinocerebellar ataxia: a gonadotrophin deficiency syndrome resistant to treatment with pulsatile gonadotrophin-releasing hormone. Clin Endocrinol [Oxf] 1999;51(4):525-9.
119. Caron P, Chauvin S, Christin-Maitre S, Bennet A, Lahlou N, Counis R, et al. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J Clin Endocrinol Metab 1999;84(3):990-6.